Journals / Türk Pediatri Arşivi / 2017 / Cilt: 52 - Sayı: 4

Two patients with Apert syndrome with different mutations: the importance of early diagnosis

Farklı mutasyonlar taşıyan Apert sendromlu iki olgu: erken tanının önemi

Pages
231–235
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conclusion, early surgical intervention should be considered in cases of Apert syndrome to prevent intellectual disability

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Apert syndrome is an autosomal dominant craniosynostosis syndrome accompanied by limb anomalies.
📊
Key Findings & Data:The fibroblast growth factor receptor 2 (FGFR2) gene is responsible for the disease and two different heterozygous mutations, p.Pro253Arg and p.Ser252Trp, have been defined as responsible in the majority of cases of Apert syndrome.
💡
Conclusion & Impact:As a conclusion, early surgical intervention should be considered in cases of Apert syndrome to prevent intellectual disability
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Apert syndrome is an autosomal dominant craniosynostosis syndrome accompanied by limb anomalies. The fibroblast growth factor receptor 2 (FGFR2) gene is responsible for the disease and two different heterozygous mutations, p.Pro253Arg and p.Ser252Trp, have been defined as responsible in the majority of cases of Apert syndrome. In this case report, two patients with Apert syndrome with two different FGFR2 gene mutations are presented. Case-1, a 4-month-old boy with craniosynostosis and syndactyly was referred to pediatric genetic clinic. The molecular analysis revealed p.Pro253Arg mutation in the FGFR2 gene, which confirmed the diagnosis of Apert syndrome. Case-2, a 16-year-old girl with developmental delay, cleft palate, syndactyly, and craniosynostosis, was also diagnosed as having Apert syndrome. A molecular diagnosis identified a p.Ser252Trp heterozygous mutation in the FGFR2 gene. Case-1 underwent surgery for craniosynostosis at age 10 months and he was developmentally normal during the 2 year follow-up period. As a conclusion, early surgical intervention should be considered in cases of Apert syndrome to prevent intellectual disability

Özet

Apert sendromu, otozomal baskın kalıtım gösteren el ve ayak anomalilerinin eşlik ettiği bir kraniyosinostoz sendromudur. Apert sendromunun büyük çoğunluğu FGFR2 (fibroblast growth factor receptor 2) geninde oluşan heterozigot p.Pro253Arg ve p.Ser252Trp mutasyonları sonucunda ortaya çıkmaktadır. Bu çalışmada iki farklı mutasyon taşıyan Apert sendromu tanılı iki olgu sunulmuştur. Dört aylık erkek olan olgu 1, kraniyosinostoz ve sindaktili nedeniyle çocuk genetik kliniğine yönlendirildi. Klinik bulgularla Apert sendromu tanısı alan hastada moleküler analiz ile tanı doğrulandı. On altı yaşında gelişim geriliği, yarık damak, parmak anomalisi ve kraniyosinostoz nedeniyle başvuran olgu 2'de, FGFR2 geninde heterozigot p.Ser252Trp mutasyonu saptandı. On aylık iken kraniyosinostoz düzeltici operasyonu yapılan olgu 1'in iki yıllık izlem boyunca nöromotor gelişiminin normal seyrettiği görüldü. Sonuç olarak, Apert sendromu olgularının erken tanı konularak, düzeltici operasyonların uygun zamanda gerçekleştirilmesi gelişim geriliğinin önlenmesi açısından oldukça önemlidir

🔖

Cite This Article

ONAY, H., ATİK, T., IŞIK, E., ÖZKINAY, F. (2022). Two patients with Apert syndrome with different mutations: the importance of early diagnosis. Türk Pediatri Arşivi, Cilt: 52 - Sayı: 4, 231–235. https://ajindex.com/articles/641114

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Cohen MM Jr, Kreiborg S, Lammer EJ, et al. Birth prevalence study of the Apert syndrome. Am J Med Genet 1992; 42: 655-9. [CrossRef ] 2. Park WJ, Theda C, Maestri NE, et al. Analysis of phenotypic features and FGFR2 mutations in Apert syndrome. Am J Hum Genet 1995; 57: 321-8. 3. Nur BG, Pehlivanoğlu S, Mıhçı E, et al. Clinicogenetic study of Turkish patients with syndromic craniosynostosis and literature review. Pediatr Neurol 2014; 50: 482-90. [CrossRef ] 4. Liu C, Cui Y, Luan J, Zhou X, Han J. The molecular and cellular basis of Apert syndrome. Intractable Rare Dis Res 2013; 2: 115-22 [CrossRef ] 5. Carinci F, Pezzetti F, Locci P, et al. Apert and Crouzon syndromes: clinical findings, genes and extracellular matrix. J Craniofac Surg 2005; 16: 361-8. [CrossRef ] 6. Oldridge M, Lunt PW, Zackai EH, et al. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum Mol Genet 1997; 6: 137- 43. [CrossRef ] 7. Slaney SF, Oldridge M, Hurst JA, et al. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet 1996; 58: 923-32. 8. Ibarra-Arce A, Ortiz de Zárate-Alarcón G, Flores-Pe-a LG, et al. Mutations in the FGFR2 gene in Mexican patients with Apert syndrome. Genet Mol Res 2015; 14: 2341-6. [CrossRef ] 9. Spruijt B, Rijken BF, Joosten KF, et al. Atypical presentation of a newborn with Apert syndrome. Childs Nerv Syst 2015; 31: 481-6. [CrossRef ] 10. Renier D, Arnaud E, Cinalli G, Sebag G, Zerah M, Marchac D. Prognosis for mental function in Apert’s syndrome. J Neurosurg 1996; 85: 66-72.[CrossRef ]